BCL2 and colorectal carcinoma: Therefore, sequential or concurrent use of Bcl-2/Bcl-xL inhibitors with DNA damaging agents represents an attractive strategy for overcoming redundancy between survival proteins and inducing mitochondrial outer membrane permeabilization in apoptosis-resistant CRC [1400,1401,1402].